We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

165 hedge funds and large institutions have $733M invested in Spectrum Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 27 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 27

5% less funds holding

Funds holding: 173 → 165 (-8)

17% less capital invested

Capital invested by funds: $881M → $733M (-$147M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

97% less call options, than puts

Call options by funds: $342K | Put options by funds: $13.6M

Holders
165
Holders Change
-8
Holders Change %
-4.62%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
82
Reduced
27
Closed
23
Calls
$342K
Puts
$13.6M
Net Calls
-$13.2M
Net Calls Change
-$12.3M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$9.25M
2
N
Nuveen
North Carolina
+$6.99M
3
BlackRock
BlackRock
New York
+$6.96M
4
Morgan Stanley
Morgan Stanley
New York
+$5.66M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$20.6M
2
Millennium Management
Millennium Management
New York
-$9.17M
3
Bank of America
Bank of America
North Carolina
-$3.03M
4
State Street
State Street
Massachusetts
-$2.83M
5
Invesco
Invesco
Georgia
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCP
151
Proficio Capital Partners
Massachusetts
$3K +$2.64K +295 New
VCM
152
Versant Capital Management
Arizona
$2K -$2.03K -227 -49%
TWA
153
TCI Wealth Advisors
Arizona
$2K – – –
WCG
154
Weaver Consulting Group
California
$2K – – –
GAM
155
Gemmer Asset Management
California
$2K +$429 +48 +20%
PCG
156
Private Capital Group
Connecticut
$2K +$796 +89 New
CAPTRUST Financial Advisors
157
CAPTRUST Financial Advisors
North Carolina
$2K +$1.79K +200 New
HGWM
158
Harvest Group Wealth Management
Massachusetts
$1K +$1.13K +126 New
GT
159
Glenmede Trust
Pennsylvania
$3 – – –
AC
160
Armistice Capital
New York
– -$20.6M -1,928,000 Closed
Millennium Management
161
Millennium Management
New York
– -$9.17M -1,025,161 Closed
AQR Capital Management
162
AQR Capital Management
Connecticut
– -$2.04M -191,027 Closed
ACM
163
Ashford Capital Management
Delaware
– -$1.53M -142,737 Closed
AIM
164
Assured Investment Management
New York
– -$989K -92,482 Closed
HI
165
HBK Investments
Texas
– -$725K -67,856 Closed
TEE
166
Tibra Equities Europe
United Kingdom
– -$676K -63,200 Closed
PIA
167
Piedmont Investment Advisors
North Carolina
– -$278K -25,962 Closed
Jane Street
168
Jane Street
New York
– -$199K -18,612 Closed
SAM
169
Shell Asset Management
Netherlands
– -$184K -17,184 Closed
PP
170
Paloma Partners
Connecticut
– -$160K -14,990 Closed
Commonwealth Equity Services
171
Commonwealth Equity Services
Massachusetts
– -$148K -13,850 Closed
ECM
172
Element Capital Management
New York
– -$132K -12,310 Closed
JT
173
Jump Trading
Illinois
– -$128K -12,000 Closed
ED
174
Exane Derivatives
France
– -$79.5K -7,440 Closed
WAM
175
Wealthspire Advisors (Maryland)
Maryland
– -$19K -1,774 Closed
4 5 6
7
8

SPPI Hedge Fund Activity: Q2 2019 in Review

165 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2019, worth a combined $733M — down 17% from $881M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 17 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 82 added.

The largest buyer was Renaissance Technologies, adding an estimated $9.25M. The largest seller was Armistice Capital, exiting entirely with an estimated $20.6M sold.

  • 165 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2019, down from 173 in Q1 2019.
  • Funds reported $733M of Spectrum Pharmaceuticals Inc stock for Q2 2019, down 17% quarter-over-quarter.
  • 17 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of -6 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2019 was Renaissance Technologies, an estimated $9.25M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2019 was Armistice Capital, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2019.